Answer:
The potential risks associated with plant-based pharmaceuticals include: pollen transfer to related species, contamination of non-transgenic crops intended for the consumption by humans, allergic reactions to the drugs produced from the genetically engineered plant, and persistence of genetically engineered material to persist in the environment and accumulate in non-target organisms. Risk assessment of plant-made pharmaceuticals should be reviewed on a case-by-case basis because the plants used to produce proteins each have different risks associated with them.
I would say to be safe age 11.
If I have a batch of pea plants with purple flowers that I grew by crossing plants that had purple flowers (PP) with plants that had white flowers (pp), purple flowers (dominant) will be expressed in this batch of pea plants.
Organic molecules, which are found mostly in food. These molecules have C-C or C-H bonds, which are high energy bonds.
Answer:
The correct answer is - Venom enzyme inhibitors.
Explanation:
The snake venoms are the complex mixtures of phospholipase A2s, disintegrins, serine proteases, C-lectins, and metalloproteases, and others. The snake venom phospholipase A2s (svPLA2s) enzymes found in most of the families of venomous snakes that cause anticoagulant effects, cardiotoxicity, neurotoxicity, and cytotoxicity, and other effects.
In antivenom, there are Venom enzyme inhibitors other than antibodies that help in neutralizing these enzymes by weakening or inhibiting these toxic actions.
